公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2023 | Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy | Lee, Yi-Mei; Hsu, Chia-Lang; Chen, Yu-Hsin; DA-LIANG OU ; CHIUN HSU ; Tan, Ching-Ting | Cancer immunology research | | | |
2015 | Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma | DA-LIANG OU ; Shyue S.-K.; LIANG-IN LIN ; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; CHIUN HSU ; ANN-LII CHENG | Oncotarget | 12 | 9 | |
2014 | H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis | Wu P.-C.; Lu J.-W.; Yang J.-Y.; Lin I.-H.; DA-LIANG OU ; Lin Y.-H.; Chou K.-H.; Huang W.-F.; Wang W.-P.; Huang Y.-L.; CHIUN HSU ; LIANG-IN LIN ; Lin Y.-M.; James Shen C.-K.; Tzeng T.-Y. | Cancer Research | 54 | 53 | |
2018 | Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy | Lin Y.-Y.; CHING-TING TAN ; Chen C.-W.; DA-LIANG OU ; ANN-LII CHENG ; CHIUN HSU | Seminars in Liver Disease | 61 | 53 | |
2009 | Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma | DA-LIANG OU ; Ying-Chun Shen ; JA-DER LIANG ; Liou J.-Y.; SUNG-LIANG YU ; Fan H.-H.; Wang D.-S.; YEN-SHEN LU ; CHIUN HSU ; ANN-LII CHENG | Clinical Cancer Research | 32 | 34 | |
2010 | Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells | DA-LIANG OU ; Ying-Chun Shen ; SUNG-LIANG YU ; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; LIANG-IN LIN ; CHIUN HSU ; ANN-LII CHENG | Cancer Research | 70 | 69 | |
2011 | IκB kinases increase Myc protein stability and enhance progression of breast cancer cells | Yeh P.-Y.; YEN-SHEN LU ; DA-LIANG OU ; ANN-LII CHENG | Molecular Cancer | 24 | 23 | |
2012 | KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | Lin Y.-L.; JAU-YU LIAU ; SHAN-CHI YU ; DA-LIANG OU ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | PLoS ONE | 43 | 35 | |
2017 | Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy | YU-YUN SHAO ; BANG-BIN CHEN ; DA-LIANG OU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; Wang, M. J.; ANN-LII CHENG ; CHIUN HSU | Alimentary Pharmacology and Therapeutics | 10 | 8 | |
2022 | Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma | YU-YUN SHAO ; Chen, Pai-Sheng; LIANG-IN LIN ; Lee, Bin-Shyun; Ling, Andrew; ANN-LII CHENG ; CHIUN HSU ; DA-LIANG OU | British journal of cancer | 8 | 10 | |
2015 | MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine | Lu J.-W.; Lin Y.-M.; Lai Y.-L.; Chen, Chien-Yuan ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Medical Oncology | 20 | 19 | |
2022 | Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer | Chiu, Wei-Chiao; DA-LIANG OU ; CHING-TING TAN | International journal of molecular sciences | 3 | 5 | |
2019 | Mouse Models for Immunotherapy in Hepatocellular Carcinoma | OU, DA-LIANG; Lin, Li; Chen, Chia-Wei; DA-LIANG OU | Cancers | 21 | 20 | |
2024 | Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer | DA-LIANG OU ; Liao, Zi-Xian; Kempson, Ivan M; Li, Lin; PAN-CHYR YANG ; Tseng, S-Ja | Journal of biomedical science | | | |
2022 | Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer | Hsieh, Ching-Hung; Jian, Cheng-Zhe; LIANG-IN LIN ; Low, Guan-Sian; Ou, Ping-Yun; CHIUN HSU ; DA-LIANG OU | Cancers | 23 | 17 | |
2014 | Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma | DA-LIANG OU ; Chang C.-J.; YUNG-MING JENG ; Lin Y.-J.; ZHONG-ZHE LIN ; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; CHIUN HSU ; ANN-LII CHENG | Journal of Gastroenterology and Hepatology (Australia) | 9 | 13 | |
2013 | Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway | DA-LIANG OU ; Lee B.-S.; Chang Y.-C.; LIANG-IN LIN ; Liou J.-Y.; CHIUN HSU ; ANN-LII CHENG | PLoS ONE | 10 | 11 | |
2021 | Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages | DA-LIANG OU ; Chen C.-W.; CHIA-LANG HSU ; Chung C.-H.; Feng Z.-R.; Lee B.-S.; ANN-LII CHENG ; Yang M.-H.; CHIUN HSU | Journal for ImmunoTherapy of Cancer | 64 | 44 | |
2022 | Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias | Su, Kuan-Wei; DA-LIANG OU ; Fu, Yu-Hsuan; HWEI-FANG TIEN ; HSIN-AN HOU ; LIANG-IN LIN | Cancer Gene Therapy | 3 | 2 | |
2008 | Role of twist in head and neck carcinoma with lymph node metastasis | DA-LIANG OU ; Chien H.-F.; Chen C.-L.; Lin T.-C.; LIANG-IN LIN | Anticancer Research | 55 | 51 | |